Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Stem Cell Reports|December 31, 2021
A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplantsPatrick Aldrin-Kirk, Malin Åkerblom, Tiago Cardoso, et al.
The Journal of Comparative Neurology|July 15, 2018
Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian ratsTiago Cardoso, Andrew F Adler, Bengt Mattsson, et al.
Cell Reports|September 26, 2019
hESC-Derived Dopaminergic Transplants Integrate into Basal Ganglia Circuitry in a Preclinical Model of Parkinson's DiseaseAndrew F Adler, Tiago Cardoso, Sara Nolbrant, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2020
Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PDDeirdre B Hoban, Shelby Shrigley, Bengt Mattsson, et al.
Stem Cell Reports|September 26, 2017
IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem CellsDaniela Lehnen, Serena Barral, Tiago Cardoso, et al.
Molecular Therapy. Methods & Clinical Development|May 30, 2023
Deconvolution of spatial sequencing provides accurate characterization of hESC-derived DA transplants in vivoJana Rájová, Marcus Davidsson, Martino Avallone, et al.
Cell Stem Cell|January 18, 2017
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's DiseaseAgnete Kirkeby, Sara Nolbrant, Katarina Tiklova, et al.
Nature Communications|July 17, 2020
Author Correction: Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson's diseaseKatarína Tiklová, Sara Nolbrant, Alessandro Fiorenzano, et al.
Nature Communications|May 17, 2020
Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson's diseaseKatarína Tiklová, Sara Nolbrant, Alessandro Fiorenzano, et al.
Cell Stem Cell|October 6, 2023
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PDAgnete Kirkeby, Jenny Nelander, Deirdre B Hoban, et al.
Pageof 3